Featured Jobs
|
Defined Benefit Specialist II or III Nova 401(k) Associates
|
|
Nova 401(k) Associates
|
|
Compensation Strategies Group, Ltd.
|
|
BPAS
|
|
DWC ERISA Consultants LLC
|
|
Merkley Retirement Consultants
|
|
EPIC RPS
|
|
July Business Services
|
|
Distributions Processor - Qualified Retirement Plans Anchor 3(16) Fiduciary Solutions, LLC
|
|
The Pension Source
|
|
Retirement Combo Plan Administrator Heritage Pension Advisors, Inc.
|
|
BPAS
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
Prescription Drug Policy, 2021 and 2022: The Year In Review, and The Year Ahead
Rachel Sachs in Health Affairs Forefront 
Jan. 7, 2022 "This past year was filled with news in the prescription drug policy area, from the [FDA's] most controversial drug approval in many years to ongoing discussions in Congress over drug pricing reform. Through it all, the importance of responding to the COVID-19 pandemic has remained at the forefront of these challenges." |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |